Related Experiment Video
Updated: Apr 16, 2026

A Tandem Liquid Chromatography–Mass Spectrometry-based Approach for Metabolite Analysis of Staphylococcus aureus
Published on: March 28, 2017
A putative cro-like repressor contributes to arylomycin resistance in Staphylococcus aureus.
Arryn Craney1, Floyd E Romesberg2
1Department of Chemistry, The Scripps Research Institute, La Jolla, California, USA.
New antibiotics called arylomycins target type I signal peptidase (SPase) in bacteria. Researchers found mutations in a specific gene help Staphylococcus aureus resist these drugs by altering cell wall synthesis.
Area of Science:
- Microbiology
- Drug Discovery
- Molecular Biology
Background:
- Antibiotic resistance is a major global health threat, driving the search for novel antibiotics.
- Arylomycins are a new class of antibiotics targeting type I signal peptidase (SPase), crucial for protein secretion.
- Limited arylomycin activity against Staphylococcus aureus necessitates understanding resistance mechanisms.
Purpose of the Study:
- Investigate the basis of limited arylomycin activity against Staphylococcus aureus.
- Characterize the transcriptional response of S. aureus to arylomycin M131.
- Identify genetic factors contributing to arylomycin resistance in S. aureus.
Main Methods:
- Assessed susceptibility of S. aureus strains to arylomycin derivatives.
- Examined the effect of tunicamycin cotreatment on arylomycin-resistant strains.
- Performed transcriptional profiling of S. aureus exposed to arylomycin M131.
- Selected for and analyzed spontaneous arylomycin-resistant mutants.
Main Results:
- Observed variable susceptibility of S. aureus to arylomycins; tunicamycin sensitized resistant strains.
- Arylomycin M131 induced upregulation of the cell wall stress stimulon and a specific operon in S. aureus.
- Mutations in a putative transcriptional regulator gene correlated with and conferred arylomycin resistance.
- In vitro selection confirmed mutations in this regulator are sufficient for resistance.
Conclusions:
- S. aureus employs specific genetic mechanisms to cope with SPase inhibition by arylomycins.
- A putative transcriptional regulator plays a key role in S. aureus resistance to arylomycin antibiotics.
- Understanding these resistance pathways is crucial for developing effective anti-staphylococcal therapies.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Prokaryotic Transcriptional Activators and Repressors
Clinical Significance of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Bacterial Protein Synthesis

